Sarcoidosis is a multisystem inflammatory disease of unknown etiology characterized by the formation of non-caseating granulomas, most commonly affecting the lungs and lymph nodes. It predominantly affects adults aged 20-40 years, with higher incidence in African Americans and Northern Europeans. Clinical presentation ranges from asymptomatic to severe organ dysfunction. While many cases resolve spontaneously, chronic progressive disease occurs in a significant subset.
name: Sarcoidosis
creation_date: '2026-01-13T07:11:10Z'
updated_date: '2026-02-27T21:53:03Z'
category: Immune
description: >
Sarcoidosis is a multisystem inflammatory disease of unknown etiology characterized
by the formation of non-caseating granulomas, most commonly affecting the lungs
and lymph nodes. It predominantly affects adults aged 20-40 years, with higher
incidence in African Americans and Northern Europeans. Clinical presentation
ranges from asymptomatic to severe organ dysfunction. While many cases resolve
spontaneously, chronic progressive disease occurs in a significant subset.
disease_term:
preferred_term: sarcoidosis
term:
id: MONDO:0019338
label: sarcoidosis
parents:
- Granulomatous Disease
- Immune-Mediated Disease
has_subtypes:
- name: Pulmonary Sarcoidosis
description: Most common form, affecting lungs and hilar lymph nodes; staged by chest radiograph findings.
- name: Cardiac Sarcoidosis
description: Myocardial granulomas causing conduction abnormalities, heart failure, or sudden death.
- name: Neurosarcoidosis
description: CNS involvement causing cranial neuropathies, meningitis, or mass lesions.
- name: Cutaneous Sarcoidosis
description: Skin manifestations including erythema nodosum, lupus pernio, and papular lesions.
pathophysiology:
- name: Granuloma Formation
description: >
Non-caseating granulomas consist of organized collections of activated
macrophages (epithelioid cells), multinucleated giant cells, and CD4+ T cells.
Th1/Th17 immune responses drive granuloma development in response to
unidentified antigens.
evidence:
- reference: PMID:35011621
supports: PARTIAL
snippet: "Sarcoidosis is a chameleon disease of unknown etiology, characterized by the growth of non-necrotizing and non-caseating granulomas"
explanation: "This review confirms the characteristic non-caseating granuloma formation in sarcoidosis."
cell_types:
- preferred_term: epithelioid macrophage
term:
id: CL:0002150
label: epithelioid macrophage
- preferred_term: CD4-positive helper T cell
term:
id: CL:0000492
label: CD4-positive helper T cell
biological_processes:
- preferred_term: granuloma formation
term:
id: GO:0002432
label: granuloma formation
- name: Dysregulated Immune Response
description: >
Exaggerated CD4+ T helper cell response with Th1 polarization leads to
interferon-gamma and TNF-alpha production. Regulatory T cell dysfunction
contributes to persistent inflammation. Paradoxical peripheral anergy
coexists with organ-specific hyperactivity.
evidence:
- reference: PMID:35011621
supports: PARTIAL
snippet: "Lungs and intrathoracic lymph nodes are the sites that are most often involved, but virtually no organ is spared from this disease."
explanation: "Review describes the multisystem inflammatory nature of sarcoidosis affecting multiple organs."
cell_types:
- preferred_term: CD4-positive helper T cell
term:
id: CL:0000492
label: CD4-positive helper T cell
biological_processes:
- preferred_term: inflammatory response
term:
id: GO:0006954
label: inflammatory response
- name: Fibrosis
description: >
Chronic granulomatous inflammation can progress to fibrosis, particularly
in the lungs. Fibroblast activation and excessive collagen deposition
lead to irreversible organ damage and functional impairment.
phenotypes:
- name: Mediastinal Lymphadenopathy
category: Pulmonary
frequency: VERY_FREQUENT
description: Symmetric enlargement of hilar and mediastinal lymph nodes, often the presenting finding on chest radiograph.
phenotype_term:
preferred_term: Mediastinal lymphadenopathy
term:
id: HP:0100721
label: Mediastinal lymphadenopathy
- name: Dyspnea
category: Pulmonary
frequency: FREQUENT
description: Shortness of breath due to pulmonary involvement and reduced lung function.
phenotype_term:
preferred_term: Dyspnea
term:
id: HP:0002094
label: Dyspnea
- name: Nonproductive Cough
category: Pulmonary
frequency: FREQUENT
description: Dry, non-productive cough from airway and parenchymal inflammation.
phenotype_term:
preferred_term: Nonproductive cough
term:
id: HP:0031246
label: Nonproductive cough
- name: Fatigue
category: Constitutional
frequency: VERY_FREQUENT
description: Chronic fatigue is one of the most debilitating symptoms, often persisting after disease resolution.
phenotype_term:
preferred_term: Fatigue
term:
id: HP:0012378
label: Fatigue
- name: Erythema Nodosum
category: Dermatologic
frequency: OCCASIONAL
description: Painful red nodules on the shins, often associated with acute sarcoidosis (Lofgren syndrome).
phenotype_term:
preferred_term: Erythema nodosum
term:
id: HP:0012219
label: Erythema nodosum
- name: Uveitis
category: Ophthalmologic
frequency: OCCASIONAL
description: Eye inflammation that can lead to vision impairment if untreated. May be anterior, posterior, or panuveitis.
phenotype_term:
preferred_term: Uveitis
term:
id: HP:0000554
label: Uveitis
biochemical:
- name: Elevated ACE
presence: Elevated
context: Serum angiotensin-converting enzyme often elevated but not specific for diagnosis
- name: Hypercalcemia
presence: Elevated
context: Due to ectopic 1,25-dihydroxyvitamin D (calcitriol) production by granuloma macrophages
- name: Elevated Inflammatory Markers
presence: Elevated
context: ESR and CRP may be elevated during active disease
genetic:
- name: HLA-DRB1 Variants
association: Susceptibility
notes: HLA-DRB1*03 associated with acute, self-limited disease; HLA-DRB1*15 with chronic disease
- name: BTNL2 Variants
association: Susceptibility
notes: Butyrophilin-like 2 gene variants increase sarcoidosis risk
environmental:
- name: Occupational Exposures
notes: Increased risk with exposure to insecticides, mold, and certain industrial dusts
- name: Infectious Triggers
notes: Mycobacterial and propionibacterial antigens have been implicated as potential triggers
treatments:
- name: Corticosteroid Therapy
description: >
First-line treatment for symptomatic sarcoidosis. Prednisone typically
initiated at 20-40mg daily with gradual taper over months. Effective
for most organ manifestations.
treatment_term:
preferred_term: corticosteroid agent therapy
term:
id: MAXO:0000640
label: corticosteroid agent therapy
- name: Methotrexate
description: >
Most commonly used steroid-sparing agent for chronic sarcoidosis.
Allows reduction of corticosteroid dose while maintaining disease control.
treatment_term:
preferred_term: pharmacotherapy
term:
id: MAXO:0000058
label: pharmacotherapy
therapeutic_agent:
- preferred_term: methotrexate
term:
id: CHEBI:44185
label: methotrexate
- name: Anti-TNF Therapy
description: >
Infliximab or adalimumab for refractory disease, particularly effective
in neurosarcoidosis, lupus pernio, and cardiac sarcoidosis.
treatment_term:
preferred_term: pharmacotherapy
term:
id: MAXO:0000058
label: pharmacotherapy
datasets: